Seeing Is Believing
SEEL is currently covered by 3 analysts with an average price target of $-2.92. This is a potential upside of $-3.22 (-1073.33%) from yesterday's end of day stock price of $0.3.
Seelos Therapeutics's activity chart (see below) currently has 5 price targets and 14 ratings on display. The stock rating distribution of SEEL is 80% BUY and 20% HOLD.
Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 340.5 days.
Highest price target for SEEL is $4, Lowest price target is $4, average price target is $-2.92.
Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 21-Sep-2023.
Currently out of the existing stock ratings of SEEL, 4 are a BUY (80%), 1 are a HOLD (20%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2
7 months 5 days ago
4/4 (100%)
$0.89 (80.18%)
140
Buy
4
$2.93 (273.83%)
7 months 5 days ago
2/2 (100%)
$-1.7 (-29.82%)
117
Buy
4
$3.8 (1900.00%)
14
11 months 11 days ago
0/3 (0%)
$8.04 (318.77%)
Buy
6
$4.93 (460.75%)
11
2 years 1 months 12 days ago
3/3 (100%)
$-19.65 (-76.61%)
641
Buy
2 years 6 months 25 days ago
2/2 (100%)
$-6.91 (-36.54%)
1145
What is SEEL (Seelos Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on SEEL (Seelos Therapeutics) with a proven track record?
Which analyst has the current lower performing score on SEEL (Seelos Therapeutics) with a proven track record?
Which analyst has the most public recommendations on SEEL (Seelos Therapeutics)?
Which analyst is the currently most bullish on SEEL (Seelos Therapeutics)?
Which analyst is the currently most reserved on SEEL (Seelos Therapeutics)?